Experience
AstraZeneca Pharmaceuticals LP; Shionogi Co.
Watson Pharmaceuticals Inc.
Successfully represented AstraZeneca and Shionogi against Watson's attempt to market a 505(b)(2) version of Crestor®.
AstraZeneca Pharmaceuticals LP; Shionogi Co. v. Watson Pharmaceuticals Inc., 1:10-cv-00915, D. Del., Judge Stark
Pronova Biopharma Norge AS v. Teva Pharmaceuticals USA, Inc.
Pronova Biopharma Norge AS
Apotex Inc. v. Senju Pharmaceutical
Senju Pharmaceuticals Co. Ltd.
Housey Pharmaceuticals, Inc. v. Otsuka Pharmaceutical Co. Ltd.
Otsuka Pharmaceutical Co. Ltd.
Hartig Drug Co. Inc. v. Senju Pharmaceutical Co. Ltd.
Senju Pharmaceuticals Co. Ltd.
AstraZeneca AB v. Lannett Holdings, Inc.
AstraZeneca AB
AstraZeneca LP v. SigmaPharm Laboratories
AstraZeneca LP
Biogen International GmbH v. Teva Pharmaceuticals USA, Inc.
Biogen International GmbH
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.